Biostar Pharmaceuticals, Inc. (BSPM)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Sep 4, 2025, 8:00 PM EDT
Biostar Pharmaceuticals Market Cap
Biostar Pharmaceuticals has a market cap or net worth of $3.00 as of September 8, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
3.00
Enterprise Value
n/a
Revenue
317.79K
Ranking
n/a
PE Ratio
0.00
Stock Price
$0.00
Market Cap Chart
Since December 18, 2008, Biostar Pharmaceuticals's market cap has decreased from 38.77M to 3.00, a decrease of -100.00%. That is a compound annual growth rate of -62.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 3.00 | - |
| Dec 30, 2024 | 3.00 | - |
| Dec 30, 2022 | 3.00 | -100.00% |
| Dec 31, 2020 | 198.84K | 25.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 749.52M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.00M |
| HealthLynked | 499.79M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |